MYD88 and B-cell chronic lymphocytic leukemia: We observed no association of expression of MYD88 with clinical stage of CLL according to Binet’s scale in PBMC with the median expression in A, B, C Binet’s stage: 0.1765 vs. 0.1605 vs. 0.2070, p = 0.4868, respectively (Figure 5B).